AlzeCure Pharma AB (ALZCUR) Stock Statistics & Valuation Metrics

AlzeCure Pharma AB has a market cap or net worth of kr252.81M. The enterprise value is kr228.68M.

AlzeCure Pharma AB has 114,914,450 shares outstanding. The number of shares has decreased by -2.65% in one year.

AlzeCure Pharma AB’s return on equity (ROE) is -1.35 and return on invested capital (ROIC) is -139.22%.

The current PE Ratio of AlzeCure Pharma AB is ―. AlzeCure Pharma AB’s PEG ratio is 0.11.

In the last 12 months, AlzeCure Pharma AB had revenue of 0.00 and earned -35.23M in profits. Earnings per share was -0.46.

In the last 12 months, operating cash flow was -25.87M and capital expenditures -124.00K, giving a free cash flow of -26.00M billion.

AlzeCure Pharma AB pays an annual dividend of ―, resulting in a dividend yield of ―

AlzeCure Pharma AB upcoming earnings date is Feb 26, 2026, TBA (Confirmed).

AlzeCure Pharma AB as a current ratio of 4.15, with Debt / Equity ratio of 5.60%

In the past 12 months, AlzeCure Pharma AB has paid 0.00 in taxes.

AlzeCure Pharma AB EV to EBITDA ratio is -1.59, with an EV/FCF ratio of -1.61.

AlzeCure Pharma AB has kr59.19M in cash and marketable securities with kr2.83M in debt, giving a net cash position of kr56.35M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for AlzeCure Pharma AB is ―, which is 11.43% higher than the current price. The consensus rating is ―